Monocytic leukemia zinc finger protein is essential for the development of long-term reconstituting hematopoietic stem cells.

Monocytic leukemia zinc finger protein (MOZ), a transcriptional coactivator and member of the MYST family of histone acetyltransferases, is the target of recurrent translocations in acute myeloid leukemia. Since genes associated with translocations in leukemia are typically important regulators of blood formation, we investigated if Moz has a role in normal hematopoiesis. We generated mice carrying a mutation in the Moz gene. Homozygous Moz mutant mice died at birth. Moz mutant fetal liver hematopoietic cells were incapable of contributing to the hematopoietic system of recipients after transplantation. We observed profound defects in the stem cell compartment of Moz-deficient mice. Progenitors of all lineages were reduced in number. However, blood cell lineage commitment was unaffected. Together, these results show that Moz is essential for a fundamental property of hematopoietic stem cells, the ability to reconstitute the hematopoietic system of a recipient after transplantation and that Moz is specifically required in the stem cell compartment.

[1]  Donald Metcalf,et al.  Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors , 2005, The Journal of experimental medicine.

[2]  D. Triglia,et al.  Further description of theLy-5 system , 1979, Immunogenetics.

[3]  K. Akashi,et al.  MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. , 2004, Cancer cell.

[4]  C. Kimmel,et al.  moz regulates Hox expression and pharyngeal segmental identity in zebrafish , 2004, Development.

[5]  R. Tjian,et al.  Regulatory diversity among metazoan co-activator complexes , 2004, Nature Reviews Molecular Cell Biology.

[6]  S. Ogawa,et al.  AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis , 2004, Nature Medicine.

[7]  Xiang-Jiao Yang.  The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases. , 2004, Nucleic acids research.

[8]  A. Voss,et al.  Querkopf, a histone acetyltransferase, is essential for embryonic neurogenesis. , 2004, Frontiers in bioscience : a journal and virtual library.

[9]  Irving L Weissman,et al.  Biology of hematopoietic stem cells and progenitors: implications for clinical application. , 2003, Annual review of immunology.

[10]  N. Kakazu,et al.  Rearrangement of the MOZ gene in pediatric therapy‐related myelodysplastic syndrome with a novel chromosomal translocation t(2;8)(p23;p11) , 2003, Genes, chromosomes & cancer.

[11]  J. Kutok,et al.  MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP. , 2003, Cancer cell.

[12]  P. Gruss,et al.  The guanine nucleotide exchange factor C3G is necessary for the formation of focal adhesions and vascular maturation , 2003, Development.

[13]  Jiang Zhu,et al.  Hematopoietic cytokines, transcription factors and lineage commitment , 2002, Oncogene.

[14]  S. Berger,et al.  Histone modifications in transcriptional regulation. , 2002, Current opinion in genetics & development.

[15]  M. Ohki,et al.  Activation of AML1‐mediated transcription by MOZ and inhibition by the MOZ–CBP fusion protein , 2001, The EMBO journal.

[16]  Perry F. Bartlett,et al.  Purification of a pluripotent neural stem cell from the adult mouse brain , 2001, Nature.

[17]  N. Kakazu,et al.  Fusion of MOZ and p300 histone acetyltransferases in acute monocytic leukemia with a t(8;22)(p11;q13) chromosome translocation , 2001, Leukemia.

[18]  P G Pelicci,et al.  Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia. , 2001, Cancer research.

[19]  J. Downing,et al.  Alterations of the AML1 transcription factor in human leukemia. , 2000, Seminars in cell & developmental biology.

[20]  Stuart H. Orkin,et al.  Diversification of haematopoietic stem cells to specific lineages , 2000, Nature Reviews Genetics.

[21]  D. Godfrey,et al.  Intrathymic T cell development and selection proceeds normally in the absence of glucocorticoid receptor signaling. , 2000, Immunity.

[22]  P. Gruss,et al.  Querkopf, a MYST family histone acetyltransferase, is required for normal cerebral cortex development. , 2000, Development.

[23]  D. Birnbaum,et al.  MOZ is fused to p300 in an acute monocytic leukemia with t(8;22) , 2000, Genes, chromosomes & cancer.

[24]  D. Livingston,et al.  Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP. , 2000, Genes & development.

[25]  C. Glass,et al.  The coregulator exchange in transcriptional functions of nuclear receptors. , 2000, Genes & development.

[26]  C. Allis,et al.  The language of covalent histone modifications , 2000, Nature.

[27]  G. Anderson,et al.  Positive selection of thymocytes: the long and winding road. , 1999, Immunology today.

[28]  Johnson M Liu,et al.  Chromatin remodeling and leukemia: new therapeutic paradigms. , 1999, Blood.

[29]  S. Minucci,et al.  Aberrant Recruitment of the Nuclear Receptor Corepressor-Histone Deacetylase Complex by the Acute Myeloid Leukemia Fusion Partner ETO , 1998, Molecular and Cellular Biology.

[30]  C. Glass,et al.  ETO, a Target of t(8;21) in Acute Leukemia, Interacts with the N-CoR and mSin3 Corepressors , 1998, Molecular and Cellular Biology.

[31]  K. Blanchard,et al.  Acute mixed lineage leukemia with an inv(8)(p11q13) resulting in fusion of the genes for MOZ and TIF2. , 1998, Blood.

[32]  T. Hoshino,et al.  ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[33]  P. Gruss,et al.  Efficiency assessment of the gene trap approach , 1998, Developmental dynamics : an official publication of the American Association of Anatomists.

[34]  R. Aguiar,et al.  A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia. , 1998, Blood.

[35]  David Newsome,et al.  Gene Dosage–Dependent Embryonic Development and Proliferation Defects in Mice Lacking the Transcriptional Integrator p300 , 1998, Cell.

[36]  A. Zelent,et al.  Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia. , 1998, Blood.

[37]  S. Inoue,et al.  Role of the histone deacetylase complex in acute promyelocytic leukaemia , 1998, Nature.

[38]  S. Minucci,et al.  Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia , 1998, Nature.

[39]  C. Tribioli,et al.  Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL , 1998, Nature Genetics.

[40]  I. Lemischka,et al.  Relative to adult marrow, fetal liver repopulates nearly five times more effectively long-term than short-term. , 1997, Experimental hematology.

[41]  P. Gruss,et al.  Germ line chimeras from female ES cells. , 1997, Experimental cell research.

[42]  C. Disteche,et al.  The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB–binding protein , 1996, Nature Genetics.

[43]  Thorsten Heinzel,et al.  A CBP Integrator Complex Mediates Transcriptional Activation and AP-1 Inhibition by Nuclear Receptors , 1996, Cell.

[44]  M. Marín‐Padilla,et al.  Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. Downing,et al.  AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis , 1996, Cell.

[46]  I. Weissman,et al.  The purification and characterization of fetal liver hematopoietic stem cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[47]  E. Dzierzak,et al.  Mouse embryonic hematopoiesis. , 1995, Trends in genetics : TIG.

[48]  I. Lemischka,et al.  Long-term repopulating abilities of enriched fetal liver stem cells measured by competitive repopulation. , 1995, Experimental hematology.

[49]  S. Avigad,et al.  A distinct subtype of M4/M5 acute myeloblastic leukemia (AML) associated with t(8:16)(p11:p13), in a patient with the variant t(8:19)(p11:q13)--case report and review of the literature. , 1995, Leukemia research.

[50]  Carroll,et al.  Cellular and molecular characterization of the role of the flk-2/flt-3 receptor tyrosine kinase in hematopoietic stem cells. , 1994, Blood.

[51]  D. Baltimore,et al.  Functional immunoglobulin transgenes guide ordered B-cell differentiation in Rag-1-deficient mice. , 1994, Genes & development.

[52]  G. Wagemaker,et al.  Stable multilineage hematopoietic chimerism in alpha-thalassemic mice induced by a bone marrow subpopulation that excludes the majority of day-12 spleen colony-forming units. , 1994, Blood.

[53]  C. Jordan,et al.  Primitive hemopoietic stem cells: direct assay of most productive populations by competitive repopulation with simple binomial, correlation and covariance calculations. , 1993, Experimental hematology.

[54]  J. Wagner,et al.  Separation of pluripotent haematopoietic stem cells from spleen colony-forming cells , 1990, Nature.

[55]  D. Metcalf.  The hemopoietic colony stimulating factors , 1984 .

[56]  J. Till,et al.  A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. , 1961, Radiation research.